Video Latest - ecancer

Atezolizumab monotherapy vs docetaxel in 2nd and 3rd line NSCLC

Prof Johan Vansteenkiste - University Hospital Leuven, Leuven, Belgium

28 Sep 2015

Latest in lung cancer from ECC 2015

Prof Martin Reck - Lung Clinic Grosshansdorf, Grosshansdorf, Germany

28 Sep 2015

COMBI-V: Melanoma survival improved by targeted drug combination

Prof Caroline Robert - Institute Gustave Roussy, Villejuif, France

28 Sep 2015

Melanoma immunotherapy latest and TVEC plus pembrolizumab

Dr Georgina Long - University of Sydney, Sydney, Australia

27 Sep 2015

Comment: New immunotherapy options for kidney cancer

Prof Martine Piccart - Jules Bordet Institute, Brussels, Belgium

26 Sep 2015

CheckMate 025 trial results: Nivolumab versus everolimus in pre-treated advanced kidney cancer

Prof Padmanee Sharma - MD Anderson Cancer Center, Houston, USA

26 Sep 2015

Nivolumab improves overall survival for advanced kidney cancer

Prof Padmanee Sharma - MD Anderson Cancer Center, Houston, USA

26 Sep 2015

METEOR trial results: Cabozantinib improves advanced kidney cancer survival

Prof Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA

26 Sep 2015

Atrial fibrillation in CLL patients on ibrutinib

Prof Florence Cymbalista – University of Paris, Paris, France

10 Sep 2015

Tumour specific immunotherapy in CLL

Prof Catherine Wu - Harvard Medical School, Boston, USA

9 Sep 2015

Phase I study of duvelisib in patients with relapsed or refractory CLL

Dr Susan O’Brien – University of California, Irvine, California, USA

$Phase I study of duvelisib in patients with relapsed or refractory CLL ( Dr Susan O’Brien – University of California, Irvine, California, USA )$

9 Sep 2015

Expert panel discussion: The best of iwCLL 2015

Prof John Gribben, Prof Michael Hallek, Dr Michael Keating, Prof Kanti Rai

9 Sep 2015

Video